News | July 23, 2012

First Patient Enrolled in the EuroEco ICD/CRT-D Trial Assessing Economic Effect of Home Monitoring

July 23, 2012 — Biotronik announced that the first CRT-D patient has been enrolled in the Biotronik EuroEco Trial — the European Health Economic Trial on Home Monitoring in implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy device (CRT-D) patients. The aim of the study is to assess the economic effects of Biotronik Home Monitoring-based remote follow-up management compared to conventional in-clinic or practice follow-ups.

In the study, the economic impact on the hospital — expressed as total follow-up cost — will be assessed and the cost effectiveness will be evaluated as a secondary analysis. The trial has been extended to incorporate CRT-D patients after more than 300 ICD patients enrolled in the first stage of the trial.

Biotronik Home Monitoring is a system that provides continuous, automatic, wireless remote monitoring of patient status and device status with daily updates — all independent of any patient interaction. The landmark trial TRUST and the COMPAS study have proven that Biotronik Home Monitoring leads to early detection of clinically relevant events and therefore to an earlier intervention and reduction of hospitalizations.

“Studies on the economic effects of remote follow-ups are still sparse,” said Dr. Hein Heidbüchel of University Hospital Leuven in Belgium, and coordinating clinical investigator of the trial. “Nevertheless, the financial implications of remote care will drive its acceptance. Authorities and hospitals will need information on how this innovative care can be adequately reimbursed. EuroEco is the first trial where an economic evaluation of remote monitoring is the primary endpoint.”

The EuroEco trial is a randomized, multicenter, international clinical trial with 312 ICD patients, and in its extension 104 CRT-D patients — a total of 416 patients in 15 European sites — with each patient having a 24-month follow-up.

“The Biotronik Home Monitoring remote follow-ups are able to enhance the safety and quality of patients’ lives by allowing for earlier detection of clinically relevant events and avoiding hospitalizations,” said Christoph Böhmer, president international at Biotronik. “We can proceed from the assumption that the systematic and continuous remote monitoring with Biotronik Home Monitoring will have clear effects on cost effectiveness and savings for the healthcare system.”

For more information: www.biotronik.com

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init